Fleming John Turman 4

What Happened

• Fleming John Turman, a director of USANA Health Sciences (USNA), had 1,057 restricted stock units (RSUs) convert into 1,057 shares on April 23, 2026. The filing shows a corresponding disposition of 1,057 shares at $0.00, which the filing format commonly reflects shares surrendered to the company (for example, to satisfy tax withholding) rather than a market sale.
• The conversion/vesting was reported as an exercise/conversion of a derivative (code M). No cash proceeds are shown for the disposition.

Key Details

• Transaction date: April 23, 2026; Form 4 filed April 27, 2026 (filed 4 days after the reported transaction; Form 4 is normally due within 2 business days).
• Acquired: 1,057 shares via conversion of RSUs (price N/A on filing). Disposed: 1,057 shares at $0.00 (reported as derivative disposition).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Footnotes: F1 — each RSU converts to one common share; F2 — these RSUs vest 25% on July 24, 2025; Oct 23, 2025; Jan 22, 2026; and Apr 23, 2026 (this transaction reflects the April 23, 2026 vesting).
• The $0.00 disposition most commonly indicates shares were withheld/surrendered to cover tax obligations; the filing does not show an open-market sale.

Context

• This was an RSU vesting/conversion event (an award being settled), not an open-market purchase or sale that indicates trading sentiment. Such transactions are routine when awards vest and are frequently accompanied by share withholding for taxes.
• The filing appears to have been submitted after the typical 2-business-day Form 4 window, which is worth noting for timeliness but does not change the substance of the vested-award transaction.